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ABSTRACT
￿
The uptake, metabolism, and action of CAMP, captured within phospholipid vesi-
cles, in H-35 hepatoma cells were studied. Sonication of lipids in buffer containing CAMP
resulted in the formation of 300-A unilamellar lipid vesicles, capturing CAMP in the internal
aqueous cavity. Incubation of H-35 hepatoma cells with vesicles containing CAMP (vesicle-
CAMP) resulted in rapid incorporation of the vesicle content; apparent saturation of uptake
was reached after -30 min of incubation at 37° C. Uptake of vesicle-CAMP was linear over a 10-
fold vesicle concentration range. Pretreatment of cells with combined inhibitors of glycolysis
and respiration inhibited vesicle uptake by 27%, suggesting vesicle fusion with the cell
membrane as a predominant pathway of vesicle uptake. Studies on the metabolism of
incorporated CAMP indicated that >50% of the cell-associated radioactivity, derived from
vesicle- [3H]cAMP, was preserved as CAMP at the end of a 20-min incubation at 37° C.
The incorporation of vesicle-cAMP by H-35 hepatoma cells resulted in increased tyrosine
aminotransferase (TAT) activity. The concentration of vesicle-cAMP needed to produce a half-
maximal increase in TAT activity was 10 p,M, approximately two orders of magnitude lower
than that of exogenously added dbcAMP. CAMP was ineffective when added extracellularly.
The kinetic relationship of the cAMP-induced increase in TAT activity and the binding of
CAMP to its receptor protein, in intact H-35 cells, was examined using vesicle-trapped 8-N3-
CAMP, a photoaffinity labeling analogue of CAMP. Incubation of H-35 hepatoma cells with
vesicle-8-N 3-cAMP resulted in increased TAT activity, preceded by the binding of 8-N3-cAMP
to the regulatory subunit of type II cAMP-dependent protein kinase.
The use of lipid vesicles provides a means of modulating intracellular CAMP concentration
without adding cyclic nucleotide in the millimolar concentration range to the extracellular
medium . The increased efficiency of intracellular delivery of cyclic nucleotide with retention
of biological activity, provides a useful technique in examining the relationship of occupancy
of specific cAMP-receptor protein(s) and the occurrence of a cAMP-mediated biological
response in intact cells.
Studies from a number of laboratories have demonstrated the
stimulatory effect of N6,02'-dibutyryl cyclic adenosine 3':5'-
monophosphate (dbcAMP), a cAMP derivative, on the synthe-
sis of tyrosine aminotransferase (TAT) (EC 2.6.1 .5) in rat liver
(16, 30, 31) and in cultured rat hepatoma cells (28, 32). Both
pretranslational (7, 8, 18) and translational (4, 5, 25) sites of
action for cAMP (and its derivatives) have been proposed;
however, the biochemical process(es) actually affected by
cAMP which leads to an increased rate of TAT synthesis is not
known. One attractive hypothesis is that this effect ofcAMP is
mediated through the activation of cAMP-dependent protein
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kinase and that subsequentphosphorylation at some site results
in the increased synthesis of TAT (13, 16, 28).
It has proven difficult to establish the involvement of a
cAMP-dependent protein kinase in more than a limited num-
ber of cAMP-regulated events. The involvement of cAMP-
dependent protein kinase in mediating the action of cAMP in
TAT induction has been examined; there is a great deal of
strong, albeit indirect, evidence obtained in intact animal stud-
ies (16) and in homogeneous cultured cell populations (28, 32,
33) that cAMP-dependent protein kinase is involved. In many
cases the abilities of various cAMP analogues to induce TAT
89were compared with theirabilities to activate cAMP-dependent
protein kinase. While a correlation between TAT induction
and protein kinase activation by various cAMP derivatives has
been shown, the use of these derivatives is not without prob-
lems. The derivatives must be used in high concentrations
because of the impermeability of the cell membrane, and there
may be differences in theiruptake and/or metabolism. Both of
these factors could affect the experimental outcome. Further-
more, the use of cyclic nucleotides at the concentrations com-
monly used for TAT induction must cause significant changes
in the absolute amounts as well as the ratio of adenine nucleo-
tides intracellularly. This could affect a variety of processes,
including the uptake and intracellular pool sizesofamino acids
and nucleotides, the synthesis of macromolecules, and any
number of enzymic reactions. Therefore, it is difficult, based
on these studies alone, to draw firm conclusions as to the
mechanism of action of cAMP and the role ofcAMP-depend-
ent protein kinase in the induction of TAT.
Lipid vesicles can be used to introduce cAMP into intact
cells (23). In the past, lipid vesicles (both unilamellar and
multilamellar) have been used as carriers of a variety of mol-
ecules into living cells. The contents of lipid vesicles are
protected from the external environment and can be incorpo-
rated intracellularly. The present report is a study of the
induction of TAT activity in H-35 hepatoma cells by cAMP
captured in lipid vesicles. The role of cAMP-dependent protein
kinase in mediating the action of cAMP is discussed.
MATERIALS AND METHODS
Cell Culture
Monolayer culture of H-35 hepatoma cells was grown in Eagle's modified
minimal essential medium (MEM) supplemented with 1017o fetal calf serum at
37'C in a waterjacketed incubator with 5% COs. At confluency the cells were
subcultured. Asolution of 0.25% pancreatin in Eagle's balanced salt solution was
added to the confluent sheet of H-35 cells and incubated at room temperature for
3 min. The solution was then aspirated off and the cells were flushed off the
bottom of the culture flask with a stream of MEM. The cell suspension was then
diluted 1:5 to 1:50 in growth medium and cells were plated in petri dishes and
incubated as described above.
Cell Counts and Viability
Cells were counted in a hemocytometer chamber, and viability was estimated
by the trypan blue dye exclusion method.
Preparation of Lipid Vesicles Containing cAMP
For the preparation of lipid vesicles containing cAMP (vesicle-cAMP), the
basic procedure of Papahadjopoulos was used (2 l). Briefly, 20pmol of phospha-
tidylcholine, 5 pmol ofstearylamine, and 15 pmol ofcholesterol in benzene were
mixed and dried under argon into athin film on the inside of a 15-ml conical
centrifuge tube. The lipids were then hydrated with 2.5 ml of a buffer containing
100 mM cAMP or ['H]CAMP (sp act 1.6 Ci/mol), 10 mM NaCl, 2 mM histidine,
0.1 mM EDTA, and 2 mM HEPES, at pH 7.4. The lipid suspension was mixed
and sonicated under argon at 40-W power output for 1 hwith a sonicater (Heat
Systems-Ultrasonics, Inc., Plainview, N. Y.) equipped with a special (stepped)
microtip. The sonication procedure was carried out at 4°-10°C. To separate
extravesicular cAMP from cAMP encapsulated in lipid vesicles, the lipid suspen-
sion was passed through a Sephadex G-50 column (25 x I cm) equilibrated with
MEM. The lipid vesicles eluted in the void volume while the extravesicular
cAMP was included in the Sephadex G-50. The efficiency ofencapsulation (i.e.,
the ratio of the amount of material remaining with the vesicles after separation
from the free material to the amount of material originally present times 100)
was generally in the rangeof 1-2%.
The concentration ofvesicle-trapped cAMPin the pooled void volume fraction
was determined by measuring the absorbance at 258 nm, correcting for the
absorbance attributable to lipid and buffer components. Alternatively, the con-
centration of vesicle-cAMP in the void volume fraction was calculated from the
amount of radioactivity in the pooled fraction and the specific activity of the
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[''H]CAMP. Similar results were obtained by these two methods. Various concen-
trations of vesicle-cAMP were made by diluting the final vesicle preparation with
MEM, such that the cAMP concentration per vesicle was constant but that the
number ofvesicles per unit volume was varied.
Characterization of Vesicle-cAMP
Vesicles containing ['H]cAMP were sized using a modified version of the
procedure described by Huang (11). Briefly, the vesicle preparation, obtained
from exclusion chromatography over aSephadex G-50 column, was applied to
a Sepharose 2B column (30 x I cm) pre-equilibrated in 10 mM Tris-HCI (pH
7.5) and 100 mM NaCl. The column was eluted with the same buffer. Alternate
fractions were assayed for total phosphate (2) and ['H]CAMP. Vesicle size was
estimated from a standard curve generated from uniformly sized Latex bead
standards (24). The elution pattern of the vesicle-cAMP thus prepared wassimilar
in all respects to that reported elsewhere for sonicated phospholipid vesicles.
Greater than 95% of the vesicles were unilamellar with an average diameter of
300 A. Based on the calculation of Huang (11), it was estimated that each 300-
A vesicle contained --4,700 lipid molecules, and that there were 1.3 x 10"
vesicles/pmol phospholipid. Themolar ratio ofencapsulated cAMP to phospho-
lipid was 250 nmol to 1 pmol.
Incorporation of Vesicle-cAMP by H-35
Hepatoma Cells
[''H]cAMP captured in lipid vesicles was used as a marker to monitor the total
cellular uptake of vesicle-cAMP. H-35 hepatoma cells at early stationary phase
of growth were used. Because of the possible effects of serum components on
leakage of material from lipid vesicles (23) and in inhibiting vesicle-cell interac-
tions (1), cells were serum deprived for 0.5-2 h before experimentation. No
differences in results were obtained using cells that were serum deprived for 0.5
hvs. cells that were serum deprived for 2 h. Various concentrations of vesicle-
cAMP were then added to individual plates ofH-35 cells and incubated at 37oC
for a predetermined period of time. At the end of this incubation period, cells
were quickly rinsed twice in phosphate-buffered saline (PBS) (pH 7.4). To
determine the amount oftotal vesicle-[''H]cAMP incorporated, 0.5 ml ofPBSwas
added to the washed H-35 cells, cells were removed from the substratum by
scraping with arubber policeman. The entire sample was then transferred to a
scintillation vial, 10 ml Aquasol was added, and the amount of cell-associated
radioactivity was determined by liquid scintillation spectrometry. Identicalplates
ofH-35 cells were used to determine protein content by the method ofLowry et
al. (15), using bovine serum albumin as standard. In some experiments, the
number of cells was counted in a hemocytometer.
Metabolism of Cell-associated [3H]cAMP
H-35 hepatoma cells at early stationary phase ofgrowth were used. Cells were
serum deprived for 0.5-2 h before their incubation with vesicle-[''H]cAMP. At
the end of a 20-min incubation period at 37°C, cells were rinsed twice in PBS
and 0.7 ml of 6% TCAwas added. TCA-precipitable material was removed by
centrifugation at 12,000gfor 3 min in an Eppendorf microfuge. The supernatant
fractions, containing cAMP and other low molecular weight substances, were
extracted three times, each with 5 ml ofwater-saturated ether. Theaqueous phase
thus obtained was blown dry with a stream of air at 40°C. The sample was then
reconstituted with 100pl water, and a20-p1 aliquot wasusedforthe determination
oftotal cell-associated radioactivity.
The remainder of the sample was spotted onto Whatman 3MM paper and
descending chromatography was carried out for 26-28 h in a solvent system of
absolute ethanol:0.5 M ammonium acetate (5:2, vol:vol) (9). Adenine nucleoside
and nucleotide standards were visualized with ultraviolet light. The RAd values,
defined as the mobility relative to that of adenosine, for ATP+ADP, AMP, and
cAMP were 0.40, 0.66, and 0.78, respectively. To determine the extent of
metabolism of the cell-incorporated [''H]cAMP, the chromatogram was cut into
I x 1 inch squares. The paper squares were soaked in 0.5 mlwaterand placed on
a metabolic shaker overnight to elute the nucleotides and/or nucleosides. After
the addition of 10 ml Aquasol, the amounts of radioactivity comigrating with
authentic ATP+ADP, AMP, or cAMP were determined by liquid scintillation
spectrometry.
Induction of TATActivity by Vesicle-cAMP
For studying the induction ofTATactivity, cells at early stationary phase of
growth were rinsed with serum-free medium, and incubated in serum-free
medium for 0-12 h. (This serum-deprivation period does not appear to have any
significant effect on the induction of TAT, but does appear to lower the basalTATactivity.) Various test agents were then added to the serum-free medium. At
designated times, cells were washed in PBS and harvested in 0.7 ml of a buffer
containing 50 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, 50 pM pyridoxal phos-
phate, and 5 mM dithiothreitol. Samples were frozen at -20°C for 24 h, and
aliquots of the cell homogenates were then assayed for TAT activity, using a
modified version of the method described by Diamondstone (6). Thestandard
assay mixture (final volume l ml) contained 100 mM potassium phosphate buffer
(pH 7.5), 5 mM tyrosine, 10 mM a-ketoglutarate, 0.1 mM pyridoxal phosphate,
1 mM EDTA, and I mM dithiothreitol. Thereaction was carried out at 37°C for
45 min, and the abwrbance at 331 nm was recorded. p-Hydroxyphenylpyruvate
(pHPP) was used as standard. Results were expressed as micrograms pHPP
formed per minute per milligram protein.
Preparation and Use of Lipid Vesicles
Containing 8-azido-adenosine 3':5'-
monophosphate
The preparation ofvesicle-containing 8-N3-cAMPwas similartothatdescribed
for vesicle-containing cAMP,except that theconcentration of8-N3-cAMP present
in the sonication buffer was 25 mM instead of 100 mM, as was the case for
cAMP. The procedure used for studying the induction of TAT by vesicle-8-N3-
cAMP was identical to that for vesicle-cAMP. To examine the labeling of
intracellular cAMP-binding protein(s) by 8-N3-cAMP, monolayer cultures ofH-
35 hepatoma cells were incubated with vesicle-8-N,-cAMP for predetermined
periods of time at 37°C. At the end of this incubation period, cells were quickly
rinsed twice in PBS, and photolyzed for 10 min with a Mineralite UVS-11
handlamp (Ultra-violet Products, Inc., San Gabriel, Calif .). Cells were removed
from thesubstratumby scraping with a rubber policeman, and were homogenized
in 10 mM Tris-HCI (pH 7.4), 50 lag/ml phenylmethylsulfonyl fluoride, and I
mM EDTA. The cell homogenates, or a 150,000 g supernatant fraction of the
homogenate, obtained from six 100-mm plates were pooled and were dialyzed
exhaustively against 2 x 4 liters of the homogenizing buffer. The available
cAMP-binding sites, of the dialyzed cell extracts from control and vesicle-&N:,-
cAMP treated H-35 hepatoma cells, were titrated by the addition of 10 pM 8-N3-
["'PIcAMP. Photoactivated incorporation of8-N3-['''P]cAMP was carried out as
described previously (29). Proteins were separated by SDS-polyacrylamide gel
electrophoresis, and autoradiographs prepared. Theamount of 8-N'-[3'P]cAMP
incorporated into protein bands of interest were quantitated by scanning the
autoradiograph with a Schoeffel SD-3000 spectromicrodensitometer (Schoeffel
Instruments Div., Kratos, Inc., Westwood, N. J.) and the peak heights of the
optical tracings were used as a quantitative measure of the incorporation of''zP.
In most experiments, the results obtained by the densitometer method were
compared with results obtained by liquid scintillation counting ofthe dried gel
slices. Similar results were obtained by the two methods. Differences in the
amount of 8-N3-["P]cAMP incorporated into a specific protein between the
control (untreated) and vesicle-8-N-cAMP-treated cells were taken as indices of
intracellular labeling of that protein by vesicle-8-N3-CAMP.
Materials
cAMP, dbcAMP, AMP, ADP, ATP, adenosine, phosphodiesterase, and other
fine biochemicals were obtained from Sigma Chemical Co. (St. Louis, Mo.). 8-
N3-cAMP was synthesized from cAMP according to the method of Muneyama
et al. (17). Stearylamine (octadecylamine) was obtained from Pflatz &Bauer Inc.
(Stamford, Conn.). Cholesterol was obtained from Calbiochem-Behring Corp.,
American Hoechst Corp. (San Diego, Calif). Phosphatidylcholine, extracted
from egg yolk by the method of Singleton et al. (26), was a gift from Dr. W.
Veatch, Department of Pharmacology, Harvard Medical School. [''H]cAMP was
obtained from New England Nuclear (Boston, Mass.). 8-N3-[32PIcAMP was
obtained from ICN Pharmaceuticals, Inc. (Irvine, Calif). Tissue culture supplies
were obtained from Grand Island Biological Co. (Grand Island, N. Y.).
RESULTS
Incorporation of Vesicle-cAMP by H-35
Hepatoma Cells
The kinetics of cellular uptake of vesicle-[3H]cAMP at 37°C,
the temperature used for all the vesicle-cell incubations re-
ported in this study, are shown in Fig. 1 . Rapid uptake of
vesicle-[3H]cAMP Occurred within the first 5-20 min, after
which uptake leveled off, reaching a plateau at -30 min and
remained at that level for incubation periods up to 2.5 h, the
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FIGURE 1
￿
Kinetics-of uptake of vesicle-[3H]cAMP by H-35 hepa-
toma cells at 37°C. H-35 hepatoma cells at early stationary phase of
growth were serum deprived for 30 min . The preparation of vesicles
containing [3H]cAMP, and the dilution of vesicle preparation to
yield cAMP concentrations of 0.5 x 10-° M and 1 x 10-° M in the
external medium were described in detail in Materials and Methods.
Results are expressed in nanomoles of [3H]cAMP incorporated per
milligram protein.
longest time point studied. The kinetics of uptake of vesicle-
[3H]cAMP for two different concentrations of vesicle appeared
similar. Because the time-course of increase in the incorpora-
tion of vesicle-[3H]cAMP was approximately linear over the
first 30 min of incubation, a 20-min incubation period was
used to give an approximation of this initial rate of incorpo-
ration of vesicle-cAMP. To measure the maximal level of
incorporation of vesicle-cAMP and to study the induction of
TAT, incubation periods longer than 30 min were used. In
some experiments, a second phase of slow increase in the
incorporation of vesicle-cAMP was observed at incubation
periods >2 h. This was observed in 5 out of 12 separate
experiments carried out over a period of 6 mo. The basis of
this phenomenon is not known; the two temporal phases of
incorporation of vesicle-cAMP by H-35 hepatoma cells could
represent distinct pathways ofentryoflipidvesicles. Incubation
of H-35 cells with these lipid vesicles had no detectable effects
on gross cell morphology or viability as determined by the
trypan blue dye exclusion technique.
Fig. 2 compares the totaluptake ofradioactivity from vesicle-
[3H]cAMP and the amount ofradioactivity remaining as cAMP
at the end of a 20-min incubation. The incorporation of
radioactivity by H-35 hepatoma cells was linear over a 10-fold
concentration range of vesicle-[3H]cAMP. The metabolism of
cAMP,although not extensive, appeared to be more significant
at lowerconcentrations of vesicle-cAMP. In general, >50% of
the totalradioactivity incorporated was recovered as cAMP. In
Figs. 1 and 2, no attempts were made to quantitate the amount
of radioactivity incorporated at time points shorter than 1 min
or at concentrations of vesicle-cAMP lower than 5 ]LM, as the
amount of radioactivity was too low for quantitation.
Lipid vesicles can become associated with cells via fusion,
endocytosis, or by stable adsorption to the cell surface; with
the predominant mechanism depending on the chemical com-
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Uptake and metabolism of vesicle-[3H]cAMP in H-35
hepatoma cells exposed to different concentrations of vesicles.
Various dilutions of vesicle- [3H]cAMP were added to H-35 hepa-
toma cells. Total uptake represents the amount of radioactivity
incorporated at theend of a20-min incubation at 37°C. The amount
of label remaining unmetabolized as cAMP was determined by
descending paper chromatography and liquid scintillation spec-
trometry. Results are presented in nanomoles of radioactivity incor-
porated per milligram protein.
position of the vesicle, the temperature of incubation, the cell
type, and other parameters (23). Studies from a number of
laboratories indicated that fusion of vesicles with the plasma
membrane is the major pathway in the cellular incorporation
of "fluid" charged lipid vesicles, e.g., the vesicle preparation
used in this study (20-23). Fusion of the vesicles with cell
membrane results in therelease of vesicle content to the inside
of a cell. On the other hand, endocytosis appears to play a
major role in the incorporation of neutral vesicles and solid
negatively charged vesicles (21, 23). The intravesicular content
of the endocytosed lipid vesicles is bound by the lipid bilayer;
its isolation from the intracellular milieu may account for its
biological inactivity (21). (It should be noted, however, that
fusion of the endocytotic vacuoles with lysosomes may result
in vesicle breakdown andrelease ofmaterial trapped inside the
vesicle.)
Endocytosis is an energy-dependent process. Inhibitors of
glycolysis and respiration have been shown to block endocy-
tosis (22). In this study, the effects of 2-deoxyglucose, an
inhibitor of glycolysis, and sodium azide, an inhibitor of res-
piration, on the incorporation of vesicle-cAMP by H-35 hepa-
toma cells were investigated (Table 1). Results demonstrated
that neither 2-deoxyglucose nor sodium azide, when added
alone, had any significant effect on the uptake of vesicle-
cAMP. The addition of 2-deoxyglucose with sodium azide to
H-35 cells resulted in a 27% decrease in the uptake of vesicle-
cAMP. The results indicate that at lease 70% of the vesicle-
cAMP enters H-35 cells by a nonendocytotic mechanism. It
also appears likely that the exposure of cells to inhibitors of
both glycolysis and respiration is necessaryto achievecomplete
inhibition ofendocytosis.
In attempting to dissociate the endocytotic and fusion path-
wayofincorporation of vesicle-cAMP by H-35 hepatoma cells,
the use of lipid vesicles bearing a net charge to entrap soluble
markers of opposite charge (in this case positively charged
stearylamine and negatively charged cAMP) may raise the
question of whether such markers are associated with both
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sides of the lipid bilayervia charge-charge interaction. Ifsuch
an interaction exists, cAMP adsorbed onto the outside of a
lipid vesicle could be incorporated into the cytoplasm by some
internalization mechanism other than fusion. This possibility
was tested by incubating vesicle-[3H]cAMP with phosphodies-
terase. Results demonstrated that, in contrast to free cAMP,
cAMP captured in lipid vesicles was protected from degrada-
tion by phosphodiesterase, suggesting its isolation from the
external environment. Control experiments demonstrated that
the addition oflipids or lipid vesicles to phosphodiesterase did
not result in inactivation of the enzyme.
An important consideration in studies on the mechanism of
incorporation of vesicle-cAMP is the possibility of adsorption
of lipid vesicle to the cell surface without true intracellular
incorporation. The process appears to predominate only at
temperatures below the gel-liquid crystalline phase transition
temperature ofthe lipid vesicle; above this temperature differ-
ent mechanisms of uptake, e.g., endocytosis or fusion, are
indicated(20). The adsorption of lipidvesicle to thecell surface
appears to involve cell surface proteins, and although these
adherent vesicles could not be removed by repeated washings
of the treated cells, they could be released by mild trypsiniza-
tion (20). In this study, the effects of mild proteolytic digestion
on the uptake of vesicle-cAMP was investigated. H-35 hepa-
toma cells were incubated with vesicle-[3H]cAMP for 20 min
at 37°C, followed by mild proteolytic digestion of cell surface
proteins. The amountsofcell-associatedradioactivity with and
without the proteolytic digestion were compared. Incubation
ofH-35 hepatoma cells with a0.25% solution ofpancreatin for
5 min at 25°C resulted in the removal of 30% of total cell-
associated radioactivity. It should be noted that the removal,
by proteolytic treatment, of 300 1o of total cell-associated radio-
activity represents an upper limit estimate of the extent of cell
surface protein-mediated adsorption of lipid vesicles. The pos-
sibility exists that this 30% loss of radioactivity may include
cell lysis or cell leakage, the release of vesicle-cAMP on the
way to fusion with the plasma membrane, in addition to the
removal of lipid vesicles adhering to cell surface proteins.
Further indication that vesicle-[3H]cAMP was actually incor-
porated into cells was provided by the recovery of >70% of the
total cell-associated radioactivity from the cytosol fraction.
TABLE I
Effect of Metabolic Inhibitors on the Uptake of Vesicle-cAMP
by H-35 Cells
plus 2-deoxyglucose (5
x 10-2 M)
H-35 hepatoma cells were pretreated with metabolic inhibitors for
1 h at 37°C. Various concentrations of vesicle-[3H]cAMP were then
added, and incubated for an additional 20 min at 37°C. Results are
expressed as percent of control uptake, taken as 100.
Uptake of vesicle-[3H]-
cAMP
vesicle-cAMP (10-° M) Aver-
1.00 0.77 0.51 0.36 age
% ofcontrol
Control 100 100 100 100 100
Sodium azide (5 x 10-3 M) 97 100 92 - 96
2-Deoxyglucose (5 x 10-2 90 80 100 - 90
M)
Sodium azide (5 x 10-3 M) 70 81 69 71 73Intracellular Metabolism of cAMP
In defining the role of cAMP in hormone action and in
studying the action of cAMP in cell function, more often than
not the effects of exogenously added cAMP or cAMP deriva-
tives on intact cell preparations were examined. Granneret al.
studied the uptake, metabolism, and action of cyclic adenine
nucleotides in cultured hepatoma cells; they found that >68%
ofthe labelfrom [3H]cAMP, [3H]mono- or [3H]dibutyrylcAMP
was in ADP or ATP, suggesting that these cyclic nucleotides
entered the cells as their respective nucleosides (9). This is in
contrast with results determined by vanRijn et al. (27). In their
study, incubation of rat hepatoma cells with [3H]dbcAMP
resulted in the equilibration of intra- andextracellular pools of
the cyclic nucleotide within 30-60 min, with >50% of the total
cell-associated radioactivity remaining as dbcAMP.
The metabolism of cell-associated cAMP was studied by
incubating H-35 hepatoma cellswith various concentrations of
vesicle-[3H]cAMP. The amount of radioactivity present in the
forms of ATP, ADP, AMP, cAMP, and adenosine was deter-
mined by descending paper chromatography and liquid scin-
tillation spectrometry. Results are shown in Table II. In all
cases, >65% ofthe total cell-associated radioactivity remained
as cAMP at the end of a 20-min incubation period at 37°C.
The amountsofradioactivity associated with ATP + ADP (not
resolved by paperchromatography), AMP, andadenosine each
represented <I0%a ofthe total radioactivity recovered. Varying
the concentration of vesicle-[3H]cAMP had no dramatic effect
on the pattern of distribution of radioactivity in the various
nucleosides and nucleotides. In some experiments, the metab-
olism ofinternalized cAMP from vesicle-cAMP wasstudied as
a function ofincubation time. Thepreservation of >50% ofthe
total cellular radioactivity in the form of cAMP was observed
TABLE II
Metabolism of Vesicle-[3 H]cAMP Incorporated by H-35 Cells
nmoll mg protein
H-35 hepatoma cells were incubated with various concentrations
of vesicle- [3H]cAMP for 20 min at 37°C. Adenine nucleotides and
nucleoside were separated by descending paper chromatography
as described in Materials and Methods. Results are expressed in
nanomoles per milligram protein; numbers in parentheses repre-
sent the percentages of radioactivity recovered as the individual
nucleotides or nucleoside, taking % radioactivity recovered as 100.
* RAa, defined as the mobility of the nucleotides relative to that of
adenosine.
$ The total amount recovered from the chromatogram, relative to
the amount loaded on .
at incubation periods of 10, 20, 30, 60, and 150min, the longest
time point studied.
Parallel experiments on theuptake andmetabolism of extra-
cellularly added [3H]cAMP were carried out. Under compara-
ble experimental conditions, theamount of totalcell associated
radioactivity following incubation of H-35 hepatoma cells in
medium containing [3H]cAMP was -20% of that after incu-
bation in medium containing vesicle-l3H]cAMP. Because of
the low amounts of radioactivity recovered, it was not possible
to studythemetabolism of cAMP ofcells incubated in medium
containing [3H]cAMP.
Induction of TAT by Vesicle-cAMP
The induction of TAT activity by vesicle-cAMP wasstudied
(a) as afunction of the concentration of vesicle-cAMP (Fig. 3),
and (b) as a function of incubation time (Fig. 4). In both cases
results obtained were compared to those of dbcAMP and
cAMP. In agreement with previous observations (27, 28, 32),
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FIGURE 3
￿
Induction of TAT in H-35 hepatoma cells by cAMP cap-
tured in phospholipid vesicles (vesicle-cAMP) (0), by exogenously
added dbcAMP (") or cAMP (") . H-35 hepatoma cells at early
stationary phase of growth were serum deprived for 10 h. Various
concentrations of vesicle-cAMP, dbcAMP, and cAMP were added
to the cells, and incubated at 37°C for 2.5 h. Cells were then
harvested and assayed for TAT activity according to methods de-
scribed in detail in text. Results are expressed in micrograms of
pHPP formed per minute per milligram protein.
INCUBATION TIME
(hours)
FIGURE 4 Kinetics of induction of TAT in H-35 hepatoma cells.
Vesicle-cAMP (50 tLM), dbcAMP (5 mM), and cAMP (5 mM) were
added to H-35 hepatoma cells, and incubated at 37°C for predeter-
mined periods of time. Results are expressed in micrograms of pHPP
formed per minute per milligram protein.
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1.10 0.08 (4) 0.08 (4) 1.76 (87) 0.09 (5) 89
0.90 0.13 (7) 0.16 (8) 1.63 (80) 0.11 (5) 88
0.68 0.13 (10) 0.13 (10) 0.95 (74) 0.08 (6) 81
0.65 0.04 (3) 0.15 (13) 1 .01 (78) 0.08 (6) 88
0.53 0.04 (4) 0.06 (10) 0.85 (82) 0.04 (4) 90
0.45 0.09 (11) 0.06 (8) 0.59 (73) 0.06 (8) 78
0.34 0.09 (14) 0.04 (7) 0.46 (71) 0.05 (8) 83
0.32 0.02 (5) 0.02 (5) 0.31 (85) 0.02 (5) 72
0.23 0.09 (20) 0.04 (8) 0.28 (63) 0.04 (9) 76
0.07 0.02 (17) 0.01 (4) 0.10 (68) 0.01 (11) 47
% Ra-
[3H]cAMP metabolic products dioac-
Vesicle- tivity
cAMP ADP + Adeno- re-
(10-4 ATP AMP cAMP sine cov-
M) 0.40* 0.66* 0.78* 1.00* ered$dbcAMP, added to the extracellular medium, caused an in-
crease in TAT activity of H-35 hepatoma cells. The concentra-
tion of dbcAMP required to produce a half-maximal increase
(EC5o) in TAT activity was 2.3 mM; the maximal TAT activity
achieved was 3.2 times that of basal activity. Under identical
experimental conditions, the concentration of vesicle-cAMP
needed to produce a half-maximal increase in TAT activity
was 10 p,M, approximately two orders of magnitude lower than
that of dbcAMP. The magnitudes of increase in TAT activity
produced by vesicle-cAMP and dbcAMP were comparable. In
contrast to cAMP captured in lipid vesicles, free cAMP added
to H-35 hepatoma cells had little effect on TAT activity, even
at a concentration as high as 1 mM. The kinetics of TAT
induction produced by dbcAMP and vesicle-cAMP appeared
similar (Fig. 4). Significant increase in TAT activity was de-
tected at 2 h, and proceeded at a rapid rate for the next 60 min,
after which the activity declined.
Labeling of Intracellular cAMP-binding
Protein(s) by Vesicle-8-N3-cAMP
cAMP-dependent protein kinase has been identified as a
major, if not the only, mediator of cAMP action in eukaryotic
cells (13). The occurrence ofa type II cAMP-dependent protein
kinase in H-35 hepatoma cells has been described (14). The
relationship of the binding of cAMP to the regulatory subunit
of the type II cAMP-dependent protein kinase (RII) and the
increase in TAT activity in intact H-35 hepatoma cells was
examined using 8-N3-cAMP, a photoaffmity labeling analogue
of cAMP, and lipid vesicles as carriers for the cyclic nucleotide
(Fig. 5). Incubation of H-35 hepatoma cells with vesicle-8-N3-
cAMP (401AM) resulted in a time-dependent increase in TAT
activity. The increase in TAT activity correlated well with the
binding of 8-N3-cAMP to RII, a protein with an apparent mol
wt of 54,000 on SDS-polyacrylamide gel electrophoresis (14,
29).
DISCUSSION
Numerous cellular functions, including the induction of TAT
in rat liver and cultured rat hepatoma cells, have been found
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FIGURE 5
￿
Kinetics of induction of TAT and labeling of the regula-
tory subunit of type II cAMP-dependent protein kinase (Rio) by
vesicle-8-N3-cAMP. The preparation of vesicle-8-N3-cAMP (40 PM)
was described in detail in the text. Vesicle-8-N3-cAMPwas added to
serum-deprived H-35 hepatoma cells, and incubated at 37°C for
predetermined periods of time. Results for the TAT activity are
expressed in micrograms of pHPP formed per minute per milligram
protein. Results for the labeling of R are expressed in picomoles of
8-N3-cAMP incorporated per milligram protein.
to be affected by dbcAMP or agents that increase cellular
cAMP levels (3). In many of these studies, exogenously added
dbcAMP has been demonstrated to be effective while equi-
molar concentrations of cAMP added to the extracellular me-
dium are either ineffective or much less effective. The reason
for the greater potency of the dibutyryl derivative is not clear.
There is no direct evidence that it penetrates cell membranes
more readily than cAMP, although this may occur and may in
some cases be the explanation for the greater potency. It is also
possible that it is more potent because it is more resistant to
inactivation by phosphodiesterase than cAMP (10, 19). Based
on the unifying hypothesis for the mechanism of action of
cAMP (13), namely, that its many and diverse effects are
mediated through activation of cAMP-dependent protein ki-
nase(s), it is generally assumed that the effects of dbcAMP on
cell function are also mediated through the activationofcAMP-
dependent protein kinase. The abilities ofdbcAMP, mbcAMP,
and cAMP to activate cytosolic cAMP-dependent protein ki-
nase obtained from rat hepatoma cells have been studied and
compared to their abilities to induce TAT activity in intact
cells (9). Results demonstrated that while cAMP is the most
effective both in competing with [3H]cAMP for binding to the
regulatory subunit and in stimulating catalytic activity of
cAMP-dependent protein kinase, it is not effective in inducing
TAT activity in intact hepatoma cells. dbcAMP, while being
the least effective analogue in activating cAMP-dependent
protein kinase, gave maximal increase in TAT activity. It is
therefore apparent that the uptake and metabolism of, as well
as the spectrum of effects produced by dbcAMP and cAMP
are not identical. In fact, apparently diametrically opposed
effects of cAMP and dbcAMP on glycogen metabolism in
HeLa-S3 cells have been reported (12). In this study, the
induction of TAT activity in H-35 hepatoma cells by cAMP
was reported, phospholipid vesicles were used as carriers to
introduce cAMP intracellularly.
Liposomes (phospholipid vesicles) have proved to be suitable
carriers for many biologically active molecules (23). In general,
liposomes form when water-insoluble polar lipids (e.g., phos-
pholipids) are confronted with water. The multilamellar lipo-
somes thus formed consist of concentric lipid bilayers. Upon
sonication, these multilamellar liposomes break up to form
smaller unilamellarlipidvesicles. Before closed structuresform,
there is unrestricted entry of water and solutes; thus, water-
soluble substances can be entrapped in the aqueous compart-
ments. In this study, we found that cAMP captured in lipid
vesicles stimulates the enzyme TAT of H-35 hepatoma cells.
There are several mechanisms by which lipid vesicles can
become associated with cells, namely, fusion, endocytosis, sta-
ble adsorption to the cell surface, and the exchange of lipid
components between the vesicle and cell membrane. The results
obtained in this study suggested that a major pathway of entry
of the vesicle-cAMP is via fusion of the lipid vesicles with the
plasma membrane of H-35 cells. Further indication that the
vesicle-cAMP was actually incorporated into cells was provided
by the recovery of>70% of[3H]cAMP from the cytosol fraction
ofthe cell homogenate. Observations on the induction of TAT
by vesicle-cAMP also support the notion that some cyclic
nucleotide was released into the cytoplasmic space.
The participation of a cAMP-dependent protein kinase in
the induction of TAT by cAMP has been strongly implicated
by a number of previous studies. Thus, the addition of cholera
toxin to H-35 hepatoma cells resulted in a dose-dependent
increase in adenyl cyclase, protein kinase, and TAT activities(32). Furthermore, the abilities of various cyclic nucleotide
derivatives in activating CAMP-dependent protein kinase cor-
relate well with their abilities to induce TAT(28, 31, 33). These
results are consistent with but do not prove a mediatory role
for cAMP-dependent protein kinase in regulating TAT synthe-
sis. In this report, the relationship of occupancy of specific
CAMP-receptor protein and TAT induction was examined in
intact H-35 cells. 8-N3-cAMP was used to covalently label
cAMP-binding sites;phospholipid vesicles were used as carriers
for the delivery of 8-N3-cAMP intracellularly. Results demon-
strated the binding of 8-N3-cAMP to the regulatory subunitof
cAMP-dependent protein kinase, and the induction of TAT
activity under the same experimental conditions.
The identification of >95% of the cAMP-binding activity as
the regulatory subunit of the type II cAMP-dependent protein
kinase in extracts ofH-35 hepatoma cells (14), the existence of
the regulatory and the catalytic subunits of cAMP-dependent
protein kinase in equimolar ratio (14), together with the obser-
vation of labeling ofRfl and induction of TAT under thesame
experimental condition, certainly indicate the mediatory role
of cAMP-dependent protein kinase in the induction of TAT
by cAMP. The use of lipid vesicles as carriers for cAMP may
provide a powerful tool in the analysis of the mechanisms of
action of cAMP.
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